Examples of using Containing active substances in English and their translations into Polish
{-}
-
Medicine
-
Official
-
Colloquial
-
Ecclesiastic
-
Ecclesiastic
-
Financial
-
Official/political
-
Programming
-
Computer
You should inform your doctor if you are taking medicines containing active substances such as those listed below.
Of plant protection products containing active substances not listed in Annex I that are already on the market two years after the date of notification of the directive.
Agenerase must not be administered concurrently with medicinal products with narrow therapeutic windows containing active substances that are substrates of cytochrome P450 3A4 CYP3A4.
As a consequence, all products containing active substances not yet evaluated would have to be withdrawn from the market.
Extending the transitional period is extremely important for guaranteeing that all biocidal products containing active substances will be placed on the market legally.
Dermatological, anti-acne serum containing active substances that have a direct effect on acne lesions.
CYP3A4 substrates with narrow therapeutic index Agenerase must not be administered concurrently with medicinal products with narrow therapeutic windows containing active substances that are substrates of cytochrome P450 3A4 CYP3A4.
Individual plant protection products containing active substances are assessed and authorised by member states under harmonised rules.
It may, in particular, according to its national rules,authorise the placing on the market in its territory of a biocidal product containing active substances not listed in Annex I or IA for that product type.
Plant protection products containing active substances can be formulated in many ways and used on a variety of crops, under different agricultural, ecological and climatic conditions.
Telzir must not be administered concurrently with medicinal products with narrow therapeutic windows containing active substances that are substrates of cytochrome P450 3A4 CYP3A4.
Hexyon is a vaccine containing active substances derived from diphtheria, tetanus, pertussis and Haemophilus influenzae type b bacteria, the hepatitis B virus, and inactivated polioviruses.
CYP3A4 substrates with narrow therapeutic index Telzir must not be administered concurrently with medicinal products with narrow therapeutic windows containing active substances that are substrates of cytochrome P450 3A4 CYP3A4.
Agenerase with ritonavir must not be co-administered with medicinal products containing active substances that are highly dependent on CYP2D6 metabolism and for which elevated plasma concentrations are associated with serious and/ or life-threatening adverse reactions.
In Article 11(2), the second sentence is replaced by the following:"Member States shall withdraw by 25 July 2003 authorisations of plant-protection products containing active substances for which no admissible notification has been submitted.
Authorisations of plant-protection products containing active substances for which no list of available studies has been submitted or for which no full data package is available shall be withdrawn by the deadline referred to in the Decision on the non-inclusion of the active substance concerned.
This Regulation shall apply to products, in the form in which they are supplied to the user,consisting of or containing active substances, safeners or synergists, and intended for one of the following uses.
As a consequence biocidal products containing active substances not listed in Annex I may no longer be placed on the market, unless inclusion into Annex I or IA to Directive 98/8/EC is applied for in accordance with Article 11 of that Directive, and provisional authorisation has been received in accordance with Article 15(2) of that Directive.
Member States should regularly re-examine whether plant protection products containing such active substances can be replaced by plant protection products containing active substances which require less risk mitigation.
In pharmacies without a doctor's prescription, syrups, dragees,tablets containing active substances that are required by the adolescent's body to eliminate such symptoms are available.
By way of derogation from Article 4 and without prejudice to paragraph 3 orto Directive 79/117/EEC, a Member State may, during a period of 12 years following the notification of this Directive, authorise the placing on the market in its territory of plant protection products containing active substances not listed in Annex I that are already on the market two years after the date of notification of this Directive.
As a result of such a comparative assessment,authorised biocidal products containing active substances indicated as candidates for substitution could be replaced with others that present significantly less risk to health or to the environment and where there are no significant adverse economic or practical impacts.
Under Article 8(2)of the Directive, a Member State could, during a period of 12 years following the notification of the Directive, authorise the placing on its national market of plant protection products containing active substances not listed in Annex I that were already on the market two years after the date of notification of the Directive, that is to say on 25 July 1993.
In accordance with Article 4(2) of Regulation(EC)No 2032/2003, placing on the market of biocidal products containing active substances not notified, or not notified for the appropriate product types, has to stop on 1 September 2006 at the latest.
CYP2D6 substrates with narrow therapeutic index Agenerase with ritonavir must not be co-administered with medicinal products containing active substances that are highly dependent on CYP2D6 metabolism and for which elevated plasma concentrations are associated with serious and/ or life-threatening adverse reactions.
CYP2D6 substrates with narrow therapeutic index Telzir with ritonavir must not be co-administered with medicinal products containing active substances that are highly dependent on CYP2D6 metabolism and for which elevated plasma concentrations are associated with serious and/ or life-threatening adverse reactions.
Article 8(2) of Directive 91/414/EEC provides that a Member State may,during a period of 12 years following the notification of that Directive, authorise the placing on the market of plant protection products containing active substances not listed in Annex I that are already on the market two years after the date of notification, except where a decision has been taken not to include a substance in Annex I.
Article 8(2) of Directive 91/414/EEC provides that a Member State may, during a period of 12 years following the notification of that Directive,authorise the placing on the market of plant protection products containing active substances not listed in Annex I to that Directive that are already on the market two years after the date of notification, while those substances are gradually being examined within the framework of a programme of work.
Chrysin contains active substances: flavones and isoflavones.
Contains active substances with slimming and firming effect and gently browning.